RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
201 hedge funds and large institutions have $2.52B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2021 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 78 increasing their positions, 55 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
201
Holders Change
-1
Holders Change %
-0.5%
% of All Funds
3.54%
Holding in Top 10
4
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-55.56%
% of All Funds
0.07%
New
38
Increased
78
Reduced
55
Closed
38
Calls
$28.7M
Puts
$43.8M
Net Calls
-$15.1M
Net Calls Change
+$11.6M
